Cysteamine

CHEMBL602 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
77.2 g/mol
LogP
-0.4
Phase
4

A free thiol compound that depletes intracellular cystine by converting it to cysteine, used to treat nephropathic cystinosis, a rare metabolic disorder causing cystine crystal accumulation in organs. It is also under investigation for other oxidative stress–related conditions.

Khối lượng phân tử

77,1500 g/mol

LogP

-0,40

TPSA

27,00 Ų

Lipinski RO5

Đạt

Lĩnh vực điều trị

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

NCCS

InChI

InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2

Molecular Formula

C2H7NS

HBD / HBA

2 / 2

Liên kết có thể quay

1

Nguyên tử nặng

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A free thiol compound that depletes intracellular cystine by converting it to cysteine, used to treat nephropathic cystinosis, a rare metabolic disorder causing cystine crystal accumulation in organs. It is also under investigation for other oxidative stress–related conditions.

Yes, Cysteamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL602. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6058. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.